Foley Partner Jacqueline Wright Bonilla appeared in a video segment published to BioCentury This Week on November 14, 2010 titled “Myriad Pro-Con.” Wright Bonilla clarifies the definition of gene patents and makes the case for a company’s right to commercialize research and development that could lead to a diagnostic in a drug. She also discusses the Assn. for Molecular Pathology, et al. v. USPTO, et al. (ACLU v. Myriad) “gene patenting” case.
Related News
March 2, 2026
In the News
Gustavo Resendiz Assesses Challenges of Private Equity Fundraising
Foley & Lardner LLP partner Gustavo Resendiz examined the challenges of private equity fundraising in the Mergers & Acquisitions article, “The State of Middle Market Fundraising.”
February 25, 2026
In the News
Susan Poll Klaessy Details Restructuring Landscape in Podcast Appearance – 'The band-aids are starting to come off'
Foley & Lardner LLP partner Susan Poll Klaessy appeared on the M&A Advisor podcast to discuss the current business restructuring landscape.
February 20, 2026
In the News
Gregory Husisian Weighs in on Impact, Next Steps in Wake of SCOTUS Tariff Ruling
Foley & Lardner LLP partner Gregory Husisian generated widespread media coverage discussing the SCOTUS ruling that President Donald Trump improperly used the International Emergency Powers Act (IEEPA) to impose tariffs.